SCHEMBL7694185

SCHEMBL7694185

CCCCC(NC(=O)c1ccccc1C=Cc1ccccc1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 10/20 0.56
CTSB P07858 6/20 0.56
CTSS P25774 2/20 0.44
CTSK P43235 2/20 0.44
CTSL P07711 2/20 0.44
NAAA Q02083 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
CA2 P00918 1/20 0.38
PRSS1 P07477 1/20 0.38
CTSG P08311 1/20 0.38
CTRB1 P17538 1/20 0.38
CMA1 P23946 1/20 0.38
FOLH1 Q04609 1/20 0.38
MAPK14 Q16539 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690836 0.94 CAPN1 (0.48) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696167 0.91 CAPN1 (0.57) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693912 0.90 CAPN1 (0.73) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697322 0.90 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693664 0.88 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693965 0.88 CAPN1 (0.46) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697828 0.87 CAPN1 (0.59) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7689853 0.87 CAPN1 (0.59) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693169 0.87 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7690557 0.86 CAPN1 (0.52) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed